Newly approved RSV vaccine in high demand, causes supply shortage problems

By CBS News
| October 12, 2023

While the shot is expected to be covered by most insurance plans, providers need to order the shot before knowing how much they'll be reimbursed. That's created a lot of frustration.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...